Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Dec 21, 2022 6:02am
465 Views
Post# 35183957

RE:RE:Reason 27 not to sell out to Big Pharma.

RE:RE:Reason 27 not to sell out to Big Pharma.

I nearly shot eggnog out my nose when I read this post, I'm laughing so hard...
Does anyone imagine for 3 seconds that this company will have trouble finding financing when it is established scientificaly that TLD-1433 + laser is a non-toxic, painless, two-to-four-treatment, non-hospitalized method that CURES YOUR CANCER?!
Do you think that money won't be pouring in from all kinds of backers when the ease, the elegance, and the efficacy of this treatment is made known? Oh, and did I mention... IT CURES YOUR CANCER?!!
What do you think the market will say when it is realized that TLT also holds the patents for a potential 10,000 related metal-based photosensitizers, which, in case I didn't mention it, MAKE YOUR CANCER AND YOUR VIRUSES DIE!!!
Forget Big Pharma, do you have any idea how many glioblastomas can be linked to Big Telelcom, and the use of cell phones? And guess what? The osmium-based photosynthesizer discovered by Dr. Sherri McFarland easily crosses the brain-blood barrier, making it absorbable by glioblastoma through the bloodstream... an important step in MAKING THE TUMOUR GO AWAY!!
You see all those lawsuit ads on American TV... Baby Powder, Camp Lejeune, Asbestos... Big Telecom is next, and they know it. Wouldn't they just love to make all those brain cancers they're causing, and which are more and more affecting young people, just go away?
Oh, and what could make them go away? Did I forget to point out...?
TLT's treatments will MAKE THEM GO AWAY!!!
And there are so many other industries that will be knocking down the door, hoping to get our treatment to market...
Because our treatment is... drumroll... THE CURE FOR CANCER!!
Take the blinkers off, folks, this stock is for people who aren't afraid of a future that is beyond bright!
GLTA Canadian Pharma-tech mavens of the future!

ScienceFirst wrote: Gojotv ...

1. How much time it takes to build a sale task force that will have it entries in oncology's physician and uro loi gists offices?  
2. How much does it cost to market your treatment?  Include sales rep salaries and travel expenses 
3. BioNTech grew much faster when teaming up with Pfizer (high of 67B$, current 37B$).
4. Say bye bye to upfront payments and royalties that could finance your GBM and NSCLC indications


 

<< Previous
Bullboard Posts
Next >>